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ABSTRACT
Classically, the nucleotide excision repair (NER) of cyclobutane pyrimidine dimers (CPD) is a
lengthy process (t1/2 > 48 h). Using the T4 endonuclease V-modified comet assay, we uniquely
found a far more rapid repair of UVA-induced CPD (t1/2 = 4.5 h) in human skin keratinocytes.
The repair of UVB-induced CPD began to slow within 1 h of irradiation, causing damage to
persist for over 36 h. A similar trend was noted for the repair of oxidatively-modified purine
nucleobases. Supportive of this differential repair, we noted an up-regulation of key genes
associated with NER in UVA-irradiated cells, whereas the same genes were down regulated in
UVB-irradiated cells. There were no significant differences in cell viability between the two
treatments over the first 6 h post-irradiation, but after 24 h apoptosis had increased significantly
in the UVB-irradiated cells. The role of apoptosis was confirmed using a pan-caspase inhibitor,
which increased CPD repair, similar to that seen with UVA. These data indicate that the
cellular ‘decision’ for apoptosis/DNA repair occurs far earlier than previously understood, and
that the induction of apoptosis leads to lesion persistence, and not vice versa. This also
highlights a new, potential increased carcinogenic risk from UVA-induced DNA damage as,
rather than undergoing apoptosis, high levels of damage are tolerated and repaired, with the
attendant risk of mutation.
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INTRODUCTION
Skin cancer has a high incidence in countries with large populations of white skinned
individuals, including the UK, USA and Australia, and the incidence continues to rise, with
UVR the principal aetiological agent in most cases (1, 2). Skin type, hair and eye colour are
predictive of skin cancer risk, implying protection by constitutive melanin, and greater DNA
repair may contribute (3). UVR is a complete carcinogen, both initiating the DNA damage that
can lead to mutagenesis, and promoting carcinogenesis, for example via immunosuppression
(1, 2), with consequential mortality (in the case of melanoma) and morbidity (non-melanoma
skin cancer). Whilst UVB (280-320 nm) constitutes a maximum of 5% of the UVR reaching
the earth’s surface, it is widely considered the most mutagenic and carcinogenic component
(4). This is largely due to its ability to damage DNA, which directly absorbs UVB, causing
dimerisation of adjacent pyrimidine nucleobases and forming cyclobutane pyrimidine dimers
(CPD) and pyrimidine (6-4) pyrimidone photoproducts (6-4)PP (5). Direct evidence for the
involvement of these lesions in carcinogenesis derives from the significant number of p53
mutations (TC → TT and CC → TT) detected at bipyrimidine sites in skin cancers. The
remaining 95% of solar UVR reaching the earth’s surface is UVA (320-400 nm). Traditionally,
there has been less concern over the contribution from UVA to skin carcinogenesis, compared
to UVB, not least because UVA is extremely poorly absorbed by DNA, and hence unlikely to
damage DNA directly. As a result, until relatively recently sunscreens provided predominantly
UVB protection, unwittingly leading to greater exposure to UVA (6). The popularity of high
intensity UVA sources in artificial tanning salons has been proposed as a route to a ‘safe tan’,
again contributing to greater exposure. However, UVA can damage DNA via the induction of
oxidative stress, leading to products such as 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-oxodG)
(7). Whilst such damage may have profound consequences for the cell (8), the failure to match
the UVA mutation spectrum to that which would be expected for 8-oxodG (a predominance of
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G:C to T:A transversions) (9, 10) has led to the suggestion that oxidative stress, and oxidatively
damaged DNA specifically, contributes to post-initiation events in UVR-induced
carcinogenesis, for example promotion (5) and immunosuppression (11).
There are a growing number of studies which have reported the induction of CPD
[T<>T, >> T<>C > C<>T (12)] by UVA (13-16) in bacteria (17), mammalian cells and skin
(7, 18-21), via a mechanism proposed to be independent of a cellular photosensitiser i.e. direct
absorption (22, 23). Nucleotide excision repair (NER) is a major DNA repair system, in all
species, and the sole mechanism for bulky adducts (24) such as CPD and (6-4)PP (25). NER
operates via two distinct pathways: global genome repair (GGR), for removal of lesions from
the overall genome; and transcription-coupled repair (TCR) that targets transcribed sequences
of actively expressing genes (reviewed in (26-28)). It is well established that the repair of (64)PP is far more effective than the repair of CPD (29-32), with the majority of (6-4)PP being
removed within 10-12 h (18), whereas >50 % of CPD persist for longer than 48 h (12),
suggesting a degree of resistance to repair (33). Indeed, there is a degree of differential repair
between the different forms of CPD, following UVB irradiation, with T<>T being the slowest,
followed by C<>C and T<>C equally, and C<>T being the fastest (34). Lesion structure, and
hence distortion of the DNA duplex, sequence context and cellular concentration of DNA
damage-sensing proteins, such as XPC and DDB2, have all been suggested as explanations for
these differences in repair rates (34). It is therefore a combination of this resistance to repair,
propensity for formation, by both UVB and UVA, and mutagenicity which gives T<>T a major
role in UVR-induced carcinogenesis. Furthermore, a few early reports have suggested that the
repair of UVA-induced T<>T is significantly slower than UVB-induced T<>T (12, 35), or even
absent in the basal layer of the epidermis (16). Such data emphasise further the importance of
T<>T, and the health risks posed by UVA. In an effort to understand better why the same
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lesion is repaired at different rates, when induced by different wavelengths, we sought to
investigate these findings in well established, in vitro human skin cell line models.
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MATERIALS AND METHODS
DNA repair enzymes T4 endonuclease V (T4endoV), human 8-oxoguanine DNA glycosylase
1 (hOGG1) and endonuclease ІІІ (endoIII), were purchased from New England-Biolabs
(Hitchin, UK). H2O2 was obtained from Sigma-Aldrich (Dorset, UK). The pan-caspase
inhibitor, Z-VAD-FMK was obtained from Promega (Madison, WI, USA).
Cell lines and culture conditions. The human keratinocyte cell line, Human adult low
Calcium high Temperature (HaCaT), was a kind gift from Professor N.E. Fusenig (Deutsches
Krebsforschungszentrum, Heidelberg, Germany (36). This cell line reveals a heteroploid
stemline with specific stable marker chromosomes, but is not tumourigenic (36). Cells at
passage number 50 were grown as a mono-layer in Nunclon culture flasks at 37 °C in a 5%
CO2 humidified incubator and in medium comprised of 1:1 DMEM/Hams F12 medium
supplemented with 10% (v/v) fetal bovine serum, 1 mM sodium pyruvate and 2 mM Glutamax.
Primary adult, human dermal fibroblasts (HDF), isolated from adult skin, were obtained from
Invitrogen (Paisley, UK). HDFs were grown as a mono-layer in Nunclon culture flasks at 37
°C in a 5% CO2 humidified incubator in fresh medium 106 (a liquid medium for the culture of
human dermal fibroblasts; Invitrogen, UK) supplemented with low serum growth supplement.
All cell culture materials were purchased from Invitrogen, Paisley, UK.
Cell treatments and post-irradiation manipulation. UVA (with a peak spectral
emission at 355 nm) and UVB (with a peak spectral emission at 310 nm) irradiations were
performed using a custom made exposure cabinet (Hybec Ltd., Leicester, UK), which contains
a bank of six Philips Cleo Performance/40W fluorescent tubes, with a Schitt Desag M-UG2
UVR transmitting absorption glass filter (HV Skan, Solihull, UK) to remove both visible and
infrared wavelengths, and six Ultraviolet-B TL20W/01 (TL01) fluorescent lamps (Philips)
which were closely spaced. The wavelength emission spectra of the lamps (including the
filtering) were characterised using a single monochromator diode array spectroradiometer, as
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previously reported

(37)

Ltd, Reading, UK).

, together with a Bentham Spectral radiometer (Bentham Instruments
Spectral analysis confirmed that Cleo Performance lamps emit a

broadband UVA spectrum (99.6% UVA, 0.4% UVB) and visible light contamination was
efficiently removed by the M-UG2 glass filter (Figure 1 A).

This very small, longer

wavelength UVB (~315-320 nm) contamination in our UVA source is unlikely to have a
significant biological effect.

Spectral analysis demonstrated that the UVB lamps were

predominantly UVB (85.9 % UVB, 14.1% UVA; Figure 1 B). The UVR intensity was
measured using a UVX Radiometer (Ultra Violet Products, Upland, USA, distributed by Fisher
Scientific, Loughborough, UK) in conjunction with a UVX-36 sensor for UVA and a UVX-31
sensor for UVB (Ultra Violet Products, Upland, USA) prior to UVR exposure.
Sub-confluent HaCaT and HDF cells (n = 30,000 for comet assay; n = 2 x 105 flow
cytometry; n = 2 x 106 for RNA extraction) were irradiated in suspension in PBS, in a petri
dish or six well plate with no lid, on ice with 10 J/cm2 UVA or 1 J/cm2 UVB. Control samples
were sham-irradiated (cells were irradiated whilst covered with aluminium foil). Following
irradiation, and prior to various investigations, cells were left in complete medium to repair for
different time points (0 min, 30 min, 1 h, 6 h, 12 h, 24 h and 36 h) at 37 °C in 5% CO2,
humidified incubator. At each time point, the adherent cells were trypsinised and used in
subsequent assays for DNA damage and repair, viability and gene expression (see below).
For the treatment of HaCaTs with H2O2, cells were seeded in 12 well plates (Greiner Bio-One
GmbH, Frickenhausen, Germany) and incubated overnight. After removing the medium, the
cells were washed with PBS, and then exposed to freshly prepared H2O2 (100 μΜ, final
concentration) for 30 min on ice. After exposure, the H2O2 was removed by washing with
PBS, medium reintroduced and the cells returned to the incubator and allowed to repair for
varying timepoints (0 min, 1 h, 3 h, 6 h, and 24 h) prior to analysis by hOGG1- and endoIIImodified comet assay (see below).
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Where indicated, HaCaTs were treated with various concentrations (0 – 300 µM) of the
caspase inhibitor Z-VAD-FMK. Treatment comprised incubation of cells with Z-VAD-fmk
for both 24 h before and 24 h after UVR exposure (inhibitor-containing medium was removed,
and irradiation performed with cells suspended in PBS, as described above). After irradiation,
cells were returned to the incubator and 24 h allowed for potential repair, prior to analysis by
T4endoV modified comet assay.
T4 endonuclease V modified alkaline comet assay. DNA damage was assessed using
T4endoV modified alkaline comet assay which recognises cyclobutane pyrimidine dimers.
Whilst there are no specific data concerning preferential activity towards the potential
combinations of pyrimidines in CPD, inferences can be made from the ability of the enzyme
to incise at all combinations of CPD, in plasmids and small bacteriophage vectors, suggesting
all are equal substrates. Furthermore, the predominant form of CPD induced by UVA and by
UVB is T<>T (12).

It has been reported that T4endoV also removes 4,6-diamino-5-

formamidopyrimdine (FapyAde) (38), a hydroxyl radical induced product of adenine, and that
this is induced by both UVC and UVB (39). However, with a level of activity (1-3% of its
activity towards CPD) that the authors conclude may not be biologically relevant in vivo (38).
This finding is entirely consistent with our studies with T4endoV modified comet assay and
cells exposed to ionising radiation (data not shown). On this basis, and under our conditions,
we conclude that there will be minimal contribution from FapyAde to the measurement of CPD
by the T4endoV modified comet assay. UVR may also generate the formation of AP sites,
which may be detected by the AP lyase activity of T4endoV, which could lead to an
overestimation of CPD. However, it is possible to discriminate between AP sites and T<>T by
plotting data derived from the alkaline comet assay alone (which representing all frank strand
breaks and those induced by the action of high pH on AP and other alkali-labile sites) versus
in conjunction with the T4endoV (which includes all of the former strand breaks, plus those
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induced by the enzyme). This is a well established approach to determine levels of strand
breaks and alkali-labile sites (which includes AP sites).
The T4endoV modified comet method was performed as described previously (37, 40)
with specific refinements of the assay for HaCaTs and HDFs. Both the concentration of, and
incubation period for, T4endoV were optimised at 0.1 U/µL and 60 min for HaCaTs and 0.02
U/µL plus 60 min for HDFs, at 37 °C in a humidified atmosphere. The remainder of the comet
assay protocol was as described below.
Human 8-oxoguanine DNA glycosylase 1-modified comet assay. DNA damage was
assessed using hOGG1-modified comet assay, as described previously (37, 40) with specific
refinements of the assay for HaCaTs and HDFs. hOGG1 recognises 8-oxo-7,8-dihydroguanine
(8-oxoGua) and 8-oxo-7,8-dihydrodenine, but also two other hydroxyl radical-induced
products, 2,6-diamino-4-hydroxy-formamidopyrimidine (FapyGua) (41) and, to a much lesser
extent, FapyAde (42). For both HaCaTs and HDFs the concentration of, and incubation period
for, hOGG1 were optimised at 3.2 U/mL and 45 min, at 37 °C in a humidified atmosphere.
Endonuclease III-modified comet assay. DNA damage was assessed using an endo
III-modification of the previously described alkaline comet assay (37, 40)), with specific
refinements of the assay for HaCaTs. Both the concentration of and incubation period for
endoIII were optimised at 10 U/mL and 45 min, at 37 °C in a humidified atmosphere. Endo
III recognises a number of free radical-induced DNA products, which are exclusively
pyrimidine-derived (e.g. thymine glycol, uracil glycol, 5-hydroxycytosine and 5hydroxyuracil) (43), with the exception of FapyAde (44).
General comet assay protocol. At each analysis time point, 3 x 104 cells from each
treatment were centrifuged at 400 x g for 4 min, then suspended in 200 μL of 0.6% low melting
point agarose. 80 μL of agarose, containing approximately 12,000 cells, were dispensed onto
glass microscope slides, pre-coated with 1% normal melting point agarose. The agarose was
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allowed to set on ice under a 22 x 22 mm cover slip (VWR International, distributed by Fisher
Scientific, Loughborough, UK). The cover slips were then removed carefully, and the slides
incubated overnight at 4 °C in lysis buffer (2.5 M NaCl, 10 mM Tris–HCl, 100 mM disodium
EDTA, pH 10 and 1% Triton X-100). On the following day, the slides were washed once with
double distilled water, and the cells then incubated with appropriate enzyme under 22 x 22 mm
cover slips (using the above optimised conditions). After the incubation period, cover slips
were removed and the slides placed in a cold (4 °C) electrophoresis tank, filled with cold
alkaline electrophoresis buffer (double distilled water, 300 mM NaOH, 1 mM disodium EDTA,
pH ≥ 13), for 20 min and then underwent electrophoresis at 27 V and 300 mA for 20 min.
Slides were neutralised with 0.4 M Tris–base, pH 7.5 for 20 min, followed by washing with
double distilled water, and then left to dry at room temperature, in the dark, overnight. On the
third day, prior to staining, slides were re-hydrated with double distilled water for 30 min, and
then covered with 2.5 μg/mL propidium iodide solution (diluted in double distilled water) for
15-20 min. Afterwards, the slides were washed again for another 30 min at room temperature
in dark and allowed to dry. All procedures were carried out under red light to decrease the
potential formation of artefactual DNA damage.

Comets were visualised by using a

combination of an on-line CCD camera, fluorescence microscopy at ×20 magnification, and
Comet Assay IV software version 4.2 (Perceptive Instruments, Suffolk, UK). 50 cells per gel
(100 cells in duplicate slides) were scored and the percentage of tail DNA in each comet was
calculated for each nucleoid image (45).
Cell Viability. Human Annexin V-FITC Apoptosis Kit (Bender Medsystems, Vienna,
Austria) was used to assess viability of HaCaTs and HDFs at the indicated post-irradiation time
points. The cells (2 x 105 cells) were trypsinised and centrifuged at 300 × g for 5 min, prior to
resuspension in 5 mL of fresh media and incubated at 37 ºC for another 30 min. Cells were
then transferred to FACS tubes and centrifuged at 300 × g for 5 min. The supernatant was
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discarded and the pellet was resuspended in 1 mL of Annexin buffer, followed by the addition
of 4 µL of Annexin V-FITC conjugate and incubation at room temperature for 10 min.
Subsequently, 30 µL (0.05 mg/mL) propidium iodide were added and incubated at room
temperature for 1 min. Finally, the cells (n=10,000 per treatment) were analysed by flow
cytometry (FACScan flow cytometer, Becton Dickinson, Oxford, UK) using CellQuest
software (Becton Dickinson, San Jose, CA).
RNA extraction. After irradiation, the HaCaTs were returned to the incubator in fresh
medium, and allowed to repair for 0 h, 6 h and 24 h, after which the cells were frozen in DMEM
containing 5% DMSO, until analysis. Total RNA was extracted from the frozen cells using
Allprep DNA/RNA/Protein Mini Kit (Qiagen, UK). RNA concentration was determined by
Nanodrop (Thermo Scientific, UK, distributed by Labtech International Ltd, Ringmer, UK).
Expression of genes associated with NER. Primer sequences were designed using
Primer 3 software (46) and the specificity of the primers tested using NCBI primer blast tools
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi?LINK_LOC=BlastHome).

The

predicted amplification product was then examined for possible primer secondary structures
and

for

duplex

formation,

by

testing

on

DNA

mfold

(http://frontend.bioinfo.rpi.edu/applications/mfold/cgi-bin/dna-form1.cgi) and Vector NTI
(64) software.

The forward and reverse oligonucleotide sequences were 5’-

TGTGATTGCCTTCTTACAACAGAG-3’ and 5’-TAGGGTTTGCCTTGGTATCTTG-3’ for
XPA;

5’-CTGCCATCCTTGGGTATTGTCGT-3’

GCCTCACCACTCTTGCTTTCTTCAG-3’

for

and

5’-

XPC;

5’-

CTAAGATGTGTATCCTGGCCGACT-3 and 5’-AAGTCCTGCTCTAGCTTCTCCATC -3’
for

ERCC1;

5’-ATGGGGAAGGTGAAGGTCG-3’

and

5’-

GGGGTCATTGATGGCAACAATATC -3’ for GAPDH.
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Two μg of isolated RNA were reverse transcribed into double-stranded cDNA with a mixture
of random primers and oligo(dT) primer using the cDNA synthesis Kit (Cedar Creek, TX).
Real-time PCR was performed on a MX4000 spectrofluorometric thermal cycler (Stratagene,
Amsterdam, The Netherlands) as described elsewhere (47).

The amplification protocol

consisted of a denaturation step at 95 °C for 4 min and 50 cycles of 95 °C for 30s, 69 °C for 1
min, and 72 °C for 30 s. Serial dilutions of a cDNA sample were amplified to generate standard
curves of amplification for each gene of interest, confirming the linear relationship between
the threshold cycle and the log (RNA input). The quantity of each transcript was determined
against the respective standard curve and normalised against both expression of the
corresponding NER gene immediately after irradiation, and expression in control sham
irradiated samples, according to Plaffl (2008) (48).
Protein extraction and Western blotting. After appropriate treatment, cells were
lysed by the addition of Laemmli buffer (2% SDS, 10% glycerol, 50mM Tris pH6.8), and the
resulting lysates heated to 94 °C for 5 min before sonication. The samples were then vortexed,
centrifuged for 1 min at 16,000 x g and then the protein concentration determined using a Pierce
BCA Protein Assay Kit (Thermo Scientific, Cramlington, UK), according to the
manufacturer’s instructions. The protein samples were loaded onto 4-10% gradient SDSPAGE gels and transferred to PVDF membrane (Immobilon–P, Millipore, Watford, UK).
Once transferred, the membrane was blocked TBS-T-milk [50 mM Tris pH 7.65, 150 mM
NaCl, 0.1% (v/v) Tween-20, 5% (w/v) fat free milk powder]. The membrane was incubated
with the primary antibody (Cell Signalling Technology, Berverly, MA, USA), diluted in TBST-BSA [50 mM Tris pH 7.65, 150 mM NaCl, 0.1% (v/v) Tween-20, 5% BSA], then washed
thoroughly with TBS-T. The membrane was then incubated with the HRP-labelled secondary
antibody (Abcam, Cambridge, UK; diluted 1:5000 in TBS-T-milk), prior to washing
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thoroughly. Bands were visualised with ECL Western Blotting Substrate (#32106, Thermo
Scientific, Rockford, USA) according to manufacturer’s instructions.
Statistical analysis.

Statistical analyses were performed using GraphPad Prism,

version 6.02 (GraphPad, CA, USA). For all variants of Comet assay, the data were evaluated
using non-parametric tests (Mann Whitney) to compare the values between two or more
groups. The level of statistical significance was set at p <0.05.

13

RESULTS
Induction of DNA damage in human skin cells exposed to UVR. Following optimisation
of the T4endoV-modified comet assay for HaCaTs, this assay demonstrated that irradiation of
HaCaTs with 10 J/cm2 UVA or 1 J/cm2 UVB lead to the induction of significant (P < 0.0001)
levels of CPD over control, sham irradiated cells (Figure 2 A and B). Performing comet
analysis in the absence of T4endoV allows for the examination of strand breaks (SB) and, at
pH >13, alkali-labile sites (ALS), which may include apurinic/apyrimidinic (AP) sites, oxidised
AP sites and certain modified nucleobases (49)depending upon the DNA damaging system
used. We also noted the formation of significant and comparable levels of SB/ALS following
both treatments, compared to control, sham irradiated cells (Figure 2 A and B).
Faster repair of UVA- versus UVB-induced CPD in human skin cells. Following
irradiation with the above doses of UVR, we monitored levels of CPD in nuclear DNA of
HaCaTs over a 36 h time period. Soon after irradiation, the repair of rate of UVB-induced
CPD decreased dramatically, with a large amount (38%) of damage still remaining after 36 h
(Figure 3 A). This overall slow repair rate is consistent with observations reported by others
in human skin [e.g. (12, 50, 51)] and cultured cells [e.g. (34, 35)] with a t1/2 > 48 h, which is
widely regarded to be characteristic of T<>T specifically. For the UVA-irradiated cells, we
again noted an initial period of rapid repair (the first ~6 h) similar to that seen for UVB-induced
CPD (Figure 3 A). However, in contrast to the UVB-irradiated cells, this faster rate of repair
was maintained over the subsequent 30 h, with levels of CPD returning to approximately
baseline (8% damage remaining) at ~24 h (Figure 3 A) and a t1/2 of 4.5 h. The divergence in
the rate of repair between UVA- and UVB-induced CPD began as early as 1 h post-irradiation
(Figure 3 A inset). As this observation was in contrast to two earlier reports which described
the repair of UVA-induced CPD to be slower than UVB-induced CPD (12, 35), we considered
it possible to have been unique to HaCaTs. We therefore repeated the above experiment using
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HDFs, a primary fibroblast culture, to address any potential issues which may be associated
with using a spontaneously transformed cell line (36). Experiments with HDFs showed the
same pattern of results we noted with HaCaTs, with the repair of UVA-induced CPD
considerably faster than that for UVB-induced CPD, which again showed the characteristic
pattern of a large amount of T<>T (54%) remaining after 36 h (Figure 3 B). As noted elsewhere
(34, 52), we observed slightly faster repair of UVB-induced CPD in keratinocytes, compared
to fibroblasts and, uniquely to our study, this also applied to UVA-induced CPD (Figure 3 A
and B). To demonstrate that the T4endoV modified Comet assay has sufficient dynamic range
to accurately report the levels of damage noted, we performed a dose-response study. This
showed that the number of CPD increased linearly with dose of UVR (Figure 3 C). It is
possible that UVR dose, and hence induced levels of damage, affects the rate of repair, although
in our experiments levels of damage induced by 10 J/cm2 UVA and 1 J/cm2 UVB were
comparable (Figure 2). To test this we examined the rate of CPD removal following increasing
doses of UVB (0.2-1.0 J/cm2), and showed that initial levels of damage had little effect on the
rate of repair, over the dose range used (Figure 3 D).
Induced levels of CPD were lower in HDFs, compared to HaCaTs, following the same
dose of either UVB or UVA (Figure 4 A and B). This is contrary to an earlier report, which
indicated the yield of T<>T and T<>C, specifically, to be higher in primary fibroblasts than
primary keratinocytes following UVB irradiation (34). Whilst this was also the case for UVAinduced SB/ALS (Figure 4 A), there was no difference in levels of SB/ALS between HaCaTs
and HDFs, following UVB irradiation (Figure 4 B). To better understand our observation of
differential CPD repair, we also examined the repair of SB/ALS, noting it to be far more rapid
than CPD, reaching approximate baseline levels within 24 h, in both HaCaTs and HDFs (Figure
4 C and D, respectively). Curiously, the repair of UVA-induced SB/ALS in HDFs was initially
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faster than that following UVB (Figure 4 D), approaching baseline levels slightly sooner than
that following UVB.
Faster repair of UVA- versus UVB-induced oxidised purines. In order to further
test the observed differential effect of UVA- and UVB-irradiation on DNA repair, we examined
the removal of 8-oxoGua, which is predominantly repaired by base excision repair, a process
distinct from NER. Using the hOGG1-modified comet assay, we noted induced levels of 8oxoGua in HaCaTs, to be significantly greater (P<0.001) following 10 J/cm2 UVA (~30 % tail
DNA), compared to 1 J/cm2 UVB (~25 % tail DNA) (Figure 5 A). The hOGG1-modified
comet assay was also used to assess repair, and we again noted that, after an initial period of
moderate repair, the rate of 8-oxoGua repair slowed in the UVB-irradiated cells, but remained
more rapid in the UVA-irradiated cells, an observation reproduced in both HaCaTs (Figure 5
B) and HDFs (Figure 5 C).
To confirm the BER rate of 8-oxoGua in HaCaTs, we determined the kinetics of lesion
loss following H2O2 treatment, as a ‘classical’ inducer of 8-oxoGua, using the hOGG1modified comet assay (Figure 5 B). This showed that repair of H2O2-induced 8-oxoGua was
similar to that of UVA-induced 8-oxoGua in both HaCaTs and HDFs (Fig 4B and C,
respectively), approaching baseline at 24 h. This finding was further supported by examining
the removal of oxidised pyrimidines in HaCaTs, again induced by H2O2, by following their
BER using the endoIII-modified comet assay (Figure 5 B)
UVB irradiation-induced apoptosis is accompanied by a down-regulation of key
NER genes. To evaluate the effects of UVR exposure on cell viability, and therefore potential
to undertake DNA repair, we examined HaCaTs for Annexin V staining, as an early indicator
of apoptosis, at several timepoints post-irradiation. Baseline levels of viability were 91%. One
hour following irradiation with UVA, this decreased to 77%, and remained at 79% at six and
24 h post-irradiation (Figure 6 A). A similar pattern was seen for UVB irradiated cells, with
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viability of 83% and 84% at one and six hours post-irradiation. However levels of viable cells
decreased dramatically to 43%, with a corresponding significant increase in apoptosis at 24 h
(Figure 6 B). This result was, to some extent, reproduced in HDFs, although these cells were
demonstrated to be much more sensitive to both UVB- and UVA-induced apoptosis than
HaCaTs (Figure 6 C and D). Indeed, this finding might explain the slower repair kinetics of
UVA-induced CPD in HDFs (Figure 3 B) compared to HaCaTs (Figure 3 A).
Concurrent with the pattern of time-dependent increase in apoptosis following UVB
irradiation seen in Figure 5 B, we noted significant, time-dependent decreases in the expression
of key NER genes (XPA, XPC and ERCC1; Figure 6 E). In contrast, for UVA, following an
initial small immediate decrease, expression of all three NER genes recovered to baseline levels
within 24 h (Figure 6 E). This sustained down regulation of NER gene expression seems likely
to account for the slower repair of UVB- versus UVA-induced CPD.
Inhibition of UVB-induced apoptosis restores DNA repair. It appeared that DNA
repair and the induction of apoptosis might be linked mechanistically. Therefore, to confirm
that UVB-induced apoptosis contributes to an overall decrease in DNA repair, as measured by
Comet assay, we investigated whether inhibition of apoptosis modulated levels of damage. We
noted a dose-responsive decrease in CPD levels, determined by T4endoV-modified comet
assay, 24 h post-UVB irradiation (Figure 7 A), following treatment of HaCaTs with increasing
concentrations of pan-caspase inhibitor Z-VAD-FMK. This clearly indicated that inhibition of
apoptosis increased DNA repair activity. As expected, cleavage of downstream factors in the
apoptotic cascade e.g. caspase-3, was prevented by Z-VAD-FMK treatment (Figure 7 B),
together with increasing the number of viable cells following UVB irradiation (Figure 7 C).
Taken together these data indicate CPD are more rapidly repaired than reported
previously, consistent with their potential mutagenicity and the importance for the cell to
exclude them from DNA. However, the induction of apoptosis in UVB irradiated cells results
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in the slow repair of CPD, together with oxidised purines. Furthermore, the induction of
apoptosis appears to be independent of the levels of damage generated by irradiation,
suggesting some other factor is the trigger for apoptosis in UVB irradiated cells.
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DISCUSSION
This is the first report of the differential repair, and description of the underlying mechanism,
of UVA- versus UVB-induced CPD and oxidatively damaged purines. This adds to a small
but growing number of reports which describe differential cellular responses to UVA and UVB
irradiation. For example, UVA is associated with conferring greater resistance to the induction
of apoptosis (53); UVA-induced, oxidatively generated purine damage is repaired faster than
UVB-induced CPD (33); UVB irradiation results in more effective cell cycle arrest, compared
to UVA (54). Our results demonstrate profound and fundamental differences in the cellular
response to UVA and UVB, which are independent of cell type, and confirm that there are
wavelength-dependant differences in the cellular response to damage.
It is conceivable, however unlikely, that subtle differences in experimental design could
contribute to the results seen here. These include: spectral characteristics of UVR source,
damage/repair detection methodology; doses of UVR used and cell type. The majority of prior
studies have only reported the peak emission wavelengths, and not described the exact emission
spectrum, making comparison with our UVR sources difficult. However, our peak emission
wavelengths for UVA and UVB are entirely consistent with those reported previously. In order
to demonstrate that the T4endoV-modified comet assay is appropriate for the study of CPD
induction and repair, we compared our rate of UVB-induced CPD with that reported in the
literature. There would appear to be broad agreement that the repair rate of T<>T, induced by
solar simulated radiation, leads to ~ 70 % T<>T remaining at 6 h, ~50 % T<>T remaining at
24 h (51, 55-57), and ~40-47% remaining at 48 h, post-exposure (55, 58, 59), using a variety
of methods (immunoassay, DNA nicking assay and 32P-postlabelling). Values, derived using
HPLC-MS/MS, tend to be higher (80% and 70% T<>T remaining after 24 and 48 h
respectively), but similarly indicate a protracted time course of lesion removal (12, 34, 35),
which has become recognised as characteristic of CPD. Taken together, these values are
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entirely consistent with our data for the repair of UVB-induced T<>T, indicating that the
T4endoV-modified comet assay is suitable for the study of CPD induction and repair. It is
possible that the induced level of T<>T, prior to repair, may somehow influence the subsequent
rate of repair, for example, as a consequence of an excess of substrate. In the studies where
the repair of UVA-induced T<>T was reported to be slower than that for UVB-induced T<>T,
initial damage levels were 4.0 T<>T/106 normal bases (induced by UVA), with 20.0 T<>T/106
normal bases (induced by UVB), a five-fold difference in damage (34); and ~4.0 T<>T/106
normal bases (induced by UVA), compared to ~4.6 T<>T/106 normal bases (induced by UVB)
(35). This indicates that the initial damage level does not influence the rate of repair. In the
present study, we examined the repair of 50 %TD (induced by UVA), with 65 %TD (induced
by UVB), clearly more comparable levels of lesion. However, on the basis of the literature it
would appear that, if at all, higher levels of T<>T leads to their faster repair (50).
Given the ‘classical’ understanding that the NER of CPD is slow, compared to the NER
of (6-4)PP or BER of oxidised purines and pyrimidines (33), the faster repair of UVA- versus
UVB-induced DNA damage, and CPD in particular, represents new and, perhaps surprising,
information. To the best of our knowledge, the only other description of the repair kinetics of
UVA-induced CPD are two reports from Douki’s group (12, 35). In both articles, the authors
note the apparent slower repair of UVA-induced CPD (T<>T, specifically), compared to UVBinduced T<>T, in contrast to our findings. Collectively, these results suggest an intrinsic
difference in how UVA-induced CPD/T<>T are processed by the cell, perhaps related to the
mechanism by which they are formed. Indeed, it has been suggested that their mechanism of
formation differs, UVB-induced CPD being generated from direct absorption by DNA (4), and
UVA-induced CPD being formed indirectly via a photosensitisation reaction; although this has
been challenged recently (22).
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The basis for this differential rate of repair appears to relate to the cellular response to
UVA or UVB irradiation. The initial rate of CPD repair is equally rapid, irrespective of
whether induced by UVA or UVB, consistent with the activation of the DNA damage response
(DDR). However, one hour post-irradiation a difference in the rate of repair begins to become
apparent. The expression of NER genes shows a down regulation following both UVA and
UVB irradiation, which would lead to a decrease in de novo synthesis of repair proteins, and
limiting the effectiveness of the DNA repair response. However, unlike the expression of NER
genes in UVB irradiated cells, whose down regulation continued to increase with time, UVA
irradiated cells produce a markedly more rapid recovery in expression, returning to baseline
levels of expression within 24 h, which is entirely consistent with the faster repair of CPD.
Our data show clearly that the slower NER of UVB-induced CPD, and indeed BER of
UVB-induced oxidatively damaged DNA, is due to the induction of apoptosis, and that
rescuing cells from apoptosis allows repair to occur. The conclusion is that UVB-induced
apoptosis significantly attenuates, but does not entirely inhibit, repair. Indeed it has been
suggested that single- and double-strand breaks (not necessarily induced by apoptosis) can lead
to the impairment of NER (60). The link between apoptosis and DNA repair is not entirely
clear. Our data show that the early induction of apoptosis causes repair to slow. However the
prevailing view appears to be that (i) DNA repair is the determinant for whether or not
apoptosis is induced, for example the efficient repair of CPD leads to the avoidance of apoptosis
(61, 62) and NER-deficient cells being extremely sensitive to UVR-induced cell death
[reviewed in (63)]; and (ii) a period of ~ 24 h is required for the cell to determine whether or
not sufficient DNA repair can occur to prevent apoptosis (64). In contrast to the above, we
propose that there is an early trigger for apoptosis which occurs shortly after UVB irradiation,
and has the effect of slowing repair which is evident within one hour. Supportive of this,
expression of NER genes is down-regulated (and remains down-regulated), soon after UVB
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irradiation. Despite this, and consistent with other studies, levels of apoptosis do not become
significant until 24 h post-irradiation, despite using Annexin V, which is a sensitive, early
marker of apoptosis. This would appear to have a more methodological, rather than biological
basis, as apoptosis is a process which requires time to become evident. Simply because
significant levels cannot be measured soon after irradiation does not demonstrate the process
has not begun.
Taken together these data indicate that the cellular decision whether to undergo
apoptosis or DNA repair is made upstream of these two processes and involves the signal
transduction of the DDR (65) e.g. via PARP-1 (66) DDB2 and XPC (67). Apoptosis and DNA
repair appear to be linked, in part, via the central role of cross-talk between histones to recruit
repair and pro-apoptotic proteins (68) and we propose that factors associated with chromatin
remodelling, or levels of binding of the above DDR elements, determine whether DNA is
repaired, or apoptosis is triggered, and our evidence indicates this to be a very early event in
the cellular response to UVR. Interestingly, recent evidence links PARP-1 with NER capacity
and chromatin remodelling (66), together with earlier evidence of a role in signalling for
apoptosis [reviewed in (69)].
The implications of this work are several-fold. Firstly, the increased cell death seen
following UVB-, compared to UVA-, irradiation may have implications for the reports which
examined DNA repair of CPD in situ in skin. Unlike in cell culture, dying and non-viable cells
cannot be easily identified in situ, and therefore their failure to repair lesions will contribute to
lesion persistence and the apparent, exaggeration of the slow rate of repair. Secondly, UVBinduced apoptosis in keratinocytes is understood to be a protective function against skin
carcinogenesis. Despite the faster repair reported here, the absence of apoptosis following
UVA irradiation, represents a potential increased health risk, particularly following exposure
to predominantly UVA sources, such as those in tanning booths, or certain therapeutic
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applications. Coupled with a report that describes UVA-induced CPD as more mutagenic than
UVB (54), the absence of apoptosis would mean no backup mechanism for any cells for which
repair was not entirely effective, and the potential for them to become cancerous. Finally, it is
clear that there is more to determining the fate of a cell, following genotoxin exposure, than
the simply the induced levels of damage. We propose that the presence or indeed persistence
of the reportedly pro-apoptotic CPD is not sufficient alone to induce apoptosis, and that early
changes in chromatin remodelling, following irradiation, are a more plausible trigger.
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Fig 1 Spectral analysis of (A) Cleo performance lamps through M-UG2 glass filter, and (B)
TL01 lamps.
A
Irradiance (linear)

Output mW/cm²

0.14
0.12
0.1
0.08
0.06
0.04
0.02
0
280

300

320

340

360

380

400

360

380

400

Wavelength (nm)

B
Irradiance (linear)
2.5

Output mW/cm²

2
1.5
1
0.5
0
280

300

320

340

Wavelength (nm)

29

Fig 2

Induction of CPD (+T4endoV) and SSB/ALS (-T4endoV) in HaCaTs following

irradiation with (A) 10 J/cm2 UVA, or (B) 1 J/cm2 UVB, determined by T4endoV-modified
comet assay immediately after irradiation. Control, sham irradiated (CSI) samples were not
irradiated. Error bars represent for mean + SEM of 300 individual determinations, from three
independent experiments.

A

D N A D a m a g e ( % t a il D N A )

100

80

P < 0 .0 0 0 1
60

40

20

0
-

T4endoV

+

-

CSI

+

1 0 J /c m

2

UVA

B

D N A D a m a g e ( % t a il D N A )

100

P < 0 .0 0 0 1

80

60

40

20

0

T4endoV

-

+

CSI

-

+

1 J /c m

2

UVB

30

Fig 3 Repair kinetics of UVA- and UVB-induced CPD repair in (A) HaCaTs, and (B) HDFs,
determined by T4endoV-modified comet assay. Cells were irradiated with 10 J/cm2 UVA or
1 J/cm2 UVB. *** represents P<0.0001 comparing UVA treated vs. UVB treated cells. Fig.
2A (inset) represents repair kinetics of UVA- and UVB-induced CPD in HaCaTs over the first
one hour post-irradiation. Error bars represent mean +/- SEM of 300 individual determinations,
from three independent experiments. Figure 3 C illustrates the dose-response for UVB-induced
CPD, determined by T4endoV-modified comet assay, for doses used in Fig. 2D. Fig. 2D
represents the kinetics of CPD repair, with increasing UVB dose; 200 individual comets from
two independent experiments were scored to generate each mean data point.
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Fig 4 Induction of CPD (+T4endoV) and SSB/ALS (-T4endoV) in HDFs following irradiation with (A) 10 J/cm2 UVA, or (B) 1 J/cm2 UVB,
determined by T4endoV-modified comet assay, immediately after irradiation. Control, sham irradiated (CSI) samples were not irradiated. Error
bars represent for mean + SEM of 300 individual determinations from three independent experiments. Repair kinetics of UVA- and UVB-induced
SSB/ALS repair in (C) HaCaTs, and (D) HDFs, determined by alkaline comet assay. Cells were irradiated with 10 J/cm2 UVA or 1 J/cm2 UVB.
Error bars represent for mean + or +/- SD of 300 individual determinations from three independent experiments.
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FIG 5 (A) Induction of oxidised purines§ (+hOGG1), predominantly 8-oxoGua, and SB/ALS (-hOGG1) in HaCaTs following irradiation with 10
J/cm2 UVA, or 1 J/cm2 UVB, determined by hOGG1-modified comet assay. Control, sham irradiated (CSI) samples were not irradiated. Error
bars represent mean + SEM of 300 individual determinations, from three independent experiments. Repair kinetics of UVA- and UVB-induced
oxidised purines in (B) HaCaTs, and (C) HDFs, determined by hOGG1-modified comet assay. Cells were irradiated with 10 J/cm2 UVA or 1
J/cm2 UVB. Error bars represent mean +/- SD of 300 individual determinations, from three independent experiments. *** represents P<0.0001
comparing UVA treated vs. UVB treated cells. (D) Repair kinetics of oxidised purines and oxidised pyrimidines§ in HaCaTs, determined by
hOGG1- and endoIII-modified comet assay, respectively, following exposure to 100 µM H2O2 for 30 min. Error bars represent mean + or +/- SD
of 300 individual determinations, from three independent experiments
§

Oxidised purines is a general term to describe the oxidatively generated nucleobase products recognized by hOGG1. We note that although the

formation of FapyGua and FapyAde are ultimately reduction products, their formation is initiated by an oxidation step. Similarly oxidised
pyrimidines is a general term to describe the oxidatively generated nucleobases products recognized by endoIII, which are exclusively pyrimidinederived, with the exception of FapyAde.
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FIG 6 Cell viability, determined by flow cytometry, and gene expression analysis. HaCaTs
were irradiated with (A) 10 J/cm2 UVA or (B) 1 J/cm2 UVB, and HDFs were irradiated with
(C) 10 J/cm2 UVA or (D) 1 J/cm2 UVB, and then allowed to repair. At time points indicated,
cells were stained with Annexin V and propidium iodide and analysed with Cell Quest
software. Control sham irradiated (CSI) samples were not irradiated. (E) Post-irradiation
changes in the expression of three key genes involved in NER (XPA, XPC and ERCC1,
normalised to the expression of GAPDH), determined by qPCR in HaCaTs treated as in (A)
and (B). Results represent the mean of (+ SD) of two independent experiments
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FIG 7 (A) Effect of Z-VAD-FMK concentration on CPD repair in HaCaT. Cells were
incubated with Z-VAD-FMK (0-300 µM) for 24 h prior, exposure to 1 J/cm2 UVB. After a
period of 24 h, to allow for potential DNA repair, cells were then analysed for CPD
(+T4endoV) by T4endoV-modified comet assay. Each bar indicates mean + SEM for 200
determinations, n=2 experiments. (B) Representative Western blot analysis of protein extract
performed as described for (A), showing effect of Z-VAM-FMK treatment upon protein
expression. Indicated on the figure is the position of the 17-kDa cleaved caspase 3 band. (C)
Cell viability, determined by flow cytometry with Annexin V and propidium iodide staining
and analysis with Cell Quest software, for two experiments performed as described in (A).
Each bar indicates mean + SEM
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